Search

A report from Hanyang University in Seoul, South Korea discusses the development of a novel indirubin derivative with enhanced anticancer properties. The compound was synthesized and evaluated in vitro and in vivo for its potential as an anticancer agent. The results showed that the compound demonstrated significant antitumor activity against various cancer cell lines and had a smaller tumor size compared to the control group and another anticancer drug. This research has been peer-reviewed and provides promising findings for the development of new anticancer treatments. [Extracted from the article]